Lọc tín hiệu
DMC

DMC

DOMESCO Medical
PharmaceuticalsHOSE
Same sector:AGPAMPBCHBCPBIOCDPCNCDANDBDDBM
54.900
+1,48%
2026-10-19

Fundamental Analysis

74 / 100ARubric: Manufacturing
Quarterly resultsRelative Valuation
CriterionLatest Q EPS growth (YoY)Avg EPS growth, last 3 (YoY)Quarters with EPS growthRevenue growth (YoY)Gross margin change (pp, YoY)Net margin change (pp, YoY)Return on Equity (TTM)Financial health (Debt/Equity)Valuation (P/E vs 5-yr median)Revenue (bn)Rev YoYNPAT (bn)NPAT YoYP/E5-Year Median P/EP/E vs. 5-Year Median
Value+78.3%+36.6%3 / 3+1.7%+4.06 pp+4.67 pp+13.7%0.008.33519+1,7%56,5+78,3%8.3310.62−21,5%
Pts128120121201212
Valuation annotation:Price: 54.900 (close price on 2026-10-19)EPS (TTM): 6.587

Financial charts

1.Revenue & growth

VND bn519Q2/26

1.Revenue & growth

VND bn519Q2/26

2.Profit & growth

VND bn56,5Q2/26

3.Profit mix (Penman)

VND bn286Q2/26

4.Margins & cost structure

%20.5%Q2/26

5.Returns & cash cycle

% · days18.7%Q2/26

6.Earnings quality & cash

VND bn88,0Q2/26

7.Asset structure

VND bn1.971Q2/26

8.Funding & debt health

VND bn · times1.971Q2/26

9.Revenue backlog

VND bn5,67Q2/26

10.Valuation

times · %8,3×Q2/26

11.EPS growth & dilution warning (CANSLIM)

VND per share; growth in %1.628Q2/26
Adjusted EPS growth, latest quarter
78.3%
Average adjusted EPS growth, 3 quarters
36.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%

Source: vnstockData through Q2/26